By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Pitcairn House
First Avenue
Burton-on-Trent  Staffordshire  DE14 2WW   United Kingdom
Phone: 44-0-1283-494-340 Fax: n/a



Company News
Clinigen Hosts Unlicensed Medicines Satellite Symposium At 22nd Congress Of EAHP 3/23/2017 9:36:08 AM
Clinigen And Diurnal Partner For European Managed Access Programme For Infacort And Chronocort 3/16/2017 8:42:11 AM
Clinigen: Strong H1 Performance With Adjusted EPS Up 31% 3/15/2017 7:54:58 AM
Clinigen Release: First-In-Class Fycompa (Perampanel) Approved In South Africa For Partial-Onset Seizures 3/10/2017 7:29:03 AM
Clinigen Release: HY Trading Update: Strong H1 Performance With Gross Profit Up 34% 1/25/2017 10:53:25 AM
Clinigen Release: Company Initiates U.S. Managed Access Program For Tesaro (TSRO)’s Niraparib For Patients With Ovarian Cancer 1/17/2017 11:31:14 AM
Clinigen Signs Global Access Agreement For BioQ's Post-Operative Pain Management Product, Ropivacaine Readyfusor 12/15/2016 10:03:58 AM
Clinigen And BTG plc (BTG.L) Extend Global Partnership With New Exclusive Global Access agreement 10/25/2016 4:04:53 PM
Clinigen Launches Japanese Business To Strengthen Asian Presence 10/18/2016 11:04:48 AM
Clinigen Release: Shaun Chilton To Take Over As Chief Executive Officer 9/28/2016 9:25:26 AM